Curaxis Pharmaceutical Corp. Announces Completion of Reverse Merger With Auto ... - MarketWatch (press release)

Curaxis Pharmaceutical Corp. Announces Completion of Reverse Merger With Auto ...
MarketWatch (press release)
Curaxis is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease and multiple cancers. ...

and more »

continue reading

Avandia: Too Dangerous...but Still for Sale? - Live in the Now

Avandia: Too Dangerous...but Still for Sale?
Live in the Now
Be cautious, and do as much research as possible before taking any pharmaceutical drug, because history tells us that the next Avandia-type scandal is just ...

and more »

continue reading

Daiichi Sankyo, Eisai 1Q Profits Grow But Takeda Stalls - Wall Street Journal


Reuters India
Daiichi Sankyo, Eisai 1Q Profits Grow But Takeda Stalls
Wall Street Journal
TO), Japan's largest pharmaceutical company, Friday said that its net profit dropped sharply in the April-June quarter while domestic rivals Daiichi Sankyo ...
Daiichi Sankyo Q1 results jump, Takeda slides Reuters
Daiichi Sankyo may raise outlook, Eisai Q1 jumps Economic Times

all 25 news articles »

continue reading

Proposed cuts to free AIDS drugs restored in NJ - BusinessWeek


The Star-Ledger - NJ.com
Proposed cuts to free AIDS drugs restored in NJ
BusinessWeek
Health and Senior Services Commissioner Dr. Poonam Alaigh said new pharmaceutical rebates and federal funds made available after July 1 enabled the state to ...
NJ says AIDS patients won't lose coverage Philadelphia Inquirer
HIV/AIDS patients will get their medications after all NorthJersey.com
N.J. restores drug funds for low-income HIV/AIDs patients newjerseynewsroom.com
The Star-Ledger - NJ.com
all 22 news articles »

continue reading

Takeda's Q1 profit slumps, outlook unchanged - Reuters

Takeda's Q1 profit slumps, outlook unchanged
Reuters
TOKYO July 30 (Reuters) - Takeda Pharmaceutical Co (4502.T), Japan's biggest drugmaker, said on Friday its April-June recurring profit fell by a quarter, ...

and more »

continue reading

Amgen 2Q Profit Drops 5.3% As Costs Rise - Wall Street Journal


RTT News
Amgen 2Q Profit Drops 5.3% As Costs Rise
Wall Street Journal
... and a $45 million payment from Takeda Pharmaceutical Co. Ltd. (4502.TO) related to its Japan collaboration on cancer drug Vectibix. ...
Amgen sees revenue, earnings grow in Q2 2010 Zenopa

all 137 news articles »

continue reading

Eli Lilly, Schlumberger, Amazon, HP, Levi Strauss: Intellectual Property - Bloomberg


TopNews United Kingdom (blog)
Eli Lilly, Schlumberger, Amazon, HP, Levi Strauss: Intellectual Property
Bloomberg
The decision is a victory for India's Sun Pharmaceutical Industries Ltd., which had challenged the patent, and generic- drug companies including Teva ...
Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co. (Fed. Cir. 2010) Patent Docs (blog)
Eli Lilly Loses Appeal in Gemzar Patent Case Wall Street Journal
SUN PHARMACEUTICAL INDUSTRIES, LTD. v. ELI LILLY AND COMPANY Leagle.com
domain-B - BusinessWeek - PR Newswire (press release)
all 98 news articles »

continue reading

Striker Energy Goes into Pharmaceutical Business - The Reverse Merger Wire

continue reading

"Do not hold everything as gold that shines like gold."

by Alain de Lille

Share this!

This Day In History

Baltimore: port town and industrial center was founded (1729)

Our Services

Do not forget to check the lastest products and auctions related to Pharmaceutical Drug as well as our free videos and podcasts.

best Pharmaceutical Drug products current Pharmaceutical Drug auctions current Pharmaceutical Drug videos listen to Pharmaceutical Drug podcasts